Sinusitis

Published on 06/06/2015 by admin

Filed under Pediatrics

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 2177 times

33 Sinusitis

Sinusitis is a frequently diagnosed but incompletely understood condition in pediatrics. Young children are estimated to have at least six to eight colds per year, and an estimated 5% to 13% of those infections are thought to be complicated by acute bacterial sinusitis (ABS). Other conditions that predispose to sinusitis include allergic rhinitis, adenoiditis, cystic fibrosis, immunodeficiency, ciliary dyskinesia, and anatomic or mechanical obstructions of normal sinus clearance. Diagnosis can be difficult because the symptoms of sinusitis overlap with those of some of its predisposing conditions; however, it is a clinically important diagnosis because of significant associated morbidity and potentially life-threatening complications.

Etiology and Pathogenesis

Paranasal sinus development begins in utero and continues until adolescence. The ethmoid and maxillary sinuses are present at birth, although the maxillary sinuses are not pneumatized until approximately 4 years of age. The sphenoid sinus is pneumatized by about 5 years of age. The frontal sinuses are present at 7 to 8 years of age, but they do not fully develop until adolescence (Figure 33-1).

The frontal, anterior ethmoid, and maxillary sinuses drain into the middle meatus of the nasal cavity through the osteomeatal complex. This structure forms a direct communication between the sinuses, which are normally sterile, and the nasopharynx, which is heavily colonized with bacteria. Under normal circumstances, sinus sterility is maintained by the mucociliary apparatus of the sinuses, which mobilizes secretions (and any bacteria that may have entered the sinus cavity) in the direction of the sinus ostia (Figure 33-2). This clearance mechanism may be compromised when the ostia are obstructed (because of mucosal inflammation and swelling, as in viral or allergic rhinitis or mechanical obstruction). The cilia do not function properly, resulting in stasis of secretions and hypoxia, which worsens edema and inflammation and creates an ideal environment for the overgrowth of bacteria (Figure 33-3).

The pathogens most commonly responsible for ABS are similar to those for acute otitis media (AOM): Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. The microbiology of ABS, as of AOM, is thought to be changing in the era of the pneumococcal conjugate vaccine and an increasing prevalence of penicillin-resistant S. pneumoniae.

Chronic sinusitis is a poorly understood phenomenon, defined by symptoms lasting for longer than 90 days without interval improvement. It is unclear how significant a role is played by bacterial infection in chronic sinusitis, with some theorizing that an inciting infection causes a prolonged inflammatory response. No clear data exist as to the most common causative agents; these infections are generally considered polymicrobial.

Rhinitis without sinus involvement is also an extremely common pediatric complaint and may be confused with sinusitis. The majority of these cases result from infection or allergy. Infectious rhinitis is caused by a number of common viruses, including rhinovirus, respiratory syncytial virus, and adenovirus, among others. Allergic rhinitis results from an immunoglobulin E–mediated response to allergens in the nasal airway, in which mast cell degranulation effects an inflammatory response resulting in edema of the nasal mucosa and the characteristic symptoms of rhinorrhea, congestion, and pruritus.

Evaluation and Management

Evaluation

The clinical diagnosis of ABS is based on history and physical examination, and it is distinguished from URI on the basis of either persistence or severity of symptoms. Persistent symptoms are defined as respiratory symptoms (nasal discharge, congestion, obstruction, or cough) lasting for more than 10 but fewer than 30 days without improvement. Severe symptoms are defined as a temperature greater than 39°C and purulent nasal discharge for 3 or 4 days in an ill-appearing child.

Radiographic imaging has a limited role in the diagnosis of ABS. Plain radiographs of the paranasal sinuses are difficult to perform and interpret in young children, and clinical history has been shown to be highly predictive of abnormal radiographs. Therefore, their routine use is not recommended in children younger than 6 years of age. Computed tomography (CT) of inflamed sinuses may demonstrate air-fluid levels, mucosal thickening, and sinus opacification; however, this modality cannot distinguish between inflammation caused by ABS and that caused by viral rhinosinusitis. The use of CT scanning in clinically diagnosed sinusitis should be reserved for patients in whom surgery is being considered, complications are suspected, or medical treatment has failed.

The gold standard for diagnosis of ABS is culture of sinus secretions obtained by maxillary sinus aspiration. This invasive procedure, which is accomplished via a transnasal approach by an otolaryngologist, is indicated only in patients with severe symptoms, failure to respond to antibiotic therapy, immunosuppression, or life-threatening complications.

Although most of this discussion has centered around acute sinusitis, other categories of diagnosis are worth mentioning. Unlike ABS, which resolves completely within 30 days, subacute sinusitis is characterized by mild to moderate symptoms, often intermittent, lasting for between 30 and 90 days, and it is caused by the same organisms as ABS. Recurrent sinusitis is characterized by three episodes of ABS within 6 months or four episodes within 12 months. Episodes of recurrent sinusitis are antibiotic responsive, and resolution of symptoms is complete between episodes. Chronic sinusitis is that lasting for more than 90 days without resolution of symptoms.

Management

Antimicrobial Therapy

Although their use is a matter of controversy, antibiotics remain the mainstay of treatment for ABS, with the goal of speeding recovery and preventing suppurative complications. When treated with an appropriate antibiotic, most patients experience improvement in respiratory symptoms within 2 to 3 days.

The first line of therapy, based on the American Academy of Pediatrics current clinical practice guidelines for sinusitis, is typically amoxicillin, at high (90 mg/kg/d divided twice daily) dosing. For patients with penicillin allergy but not a type 1 hypersensitivity reaction, cefdinir, cefuroxime, or cefpodoxime is recommended. In patients with history of type 1 hypersensitivity reaction to penicillin, clarithromycin or azithromycin is recommended.

Patients in certain populations should receive an alternative regimen. These patients include those with illness refractory to first-line therapy, moderate or more severe illness, history of recent antimicrobial therapy, or attendance at day care. For this group, amoxicillin–clavulanate is recommended (80-90 mg/kg/d of amoxicillin component divided twice daily). Cefdinir, cefuroxime, and cefpodoxime may be used as alternatives in these patients.

Patients who fail to improve with a second course of antibiotics and those who are acutely ill may be treated with intravenous cefotaxime or ceftriaxone. They may also be referred to an otolaryngologist at this point for evaluation for sinus aspiration.

At this time, there are no definitive recommendations about the length of antibiotic treatment for patients with ABS. Some clinicians empirically treat for 10, 14, 21, or 28 days; others prescribe therapy until the patient is symptom free and then for an additional 7 days. Similarly, there is little consensus about the appropriate length of treatment for patients with chronic sinusitis, with most practitioners opting for long courses of antibiotics, generally at least 4 to 6 weeks.